Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.53
-$0.01-1.13%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.45M | -3.20M | -3.37M | -4.01M | -6.05M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 214.60K | 584.40K | 410.60K | 486.20K | 384.20K |
| Change in Net Operating Assets | 117.90K | -1.19M | -2.84M | -2.06M | 656.70K |
| Cash from Operations | -2.12M | -3.80M | -5.80M | -5.59M | -5.01M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 406.90K | -- | -- |
| Total Debt Repaid | -87.20K | -175.60K | 0.00 | -113.20K | -111.10K |
| Issuance of Common Stock | -- | 11.73M | 6.65M | 8.52M | 10.20M |
| Repurchase of Common Stock | -97.70K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -184.90K | 11.55M | 7.05M | 8.41M | 10.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.30M | 7.75M | 1.26M | 2.82M | 5.07M |